WINSTON-SALEM — Novant Health is the first health care system in the Carolinas to offer histotripsy, a groundbreaking ...

Study researchers found no link between more liver fat and poor outcomes in patients with stage I-III rectal cancer.

The EMA’s recommendation follows evidence that the targeted therapy improves progression-free survival in patients whose ...

Immunotherapy—could that be an option for me, doctor?” is a question frequently asked by patients with colorectal cancer. The ...

Early detection and proactive health management are crucial in cancer treatment, as highlighted by the patient's initial symptoms and subsequent monitoring. Lifestyle changes, including dietary ...

Delcath Systems Inc. (NASDAQ:DCTH) saw its shares rise 2.2% in premarket trading Thursday after new research underscored the potential survival benefits of its liver-targeted treatment for metastatic ...

Reported late-breaking Phase 2 data at SITC for vilastobart demonstrating a 40% ORR in heavily pretreated patients with MSS mCRC without liver ...

Endocrine therapy is generally recommended for patients with HR+/HER2-metastatic breast cancer, with the exception of those ...

Chromosome compartment analysis of a cancer cell line cohort reveals different subsets of compartment changes where some track epithelial to mesenchymal transition while others reflect secondary ...